-
Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer [Elektronski vir] : SafeHer phase III study's primary analysis of 2573 patientsGligorov, Joseph ...Source: European journal of cancer [Elektronski vir]. - ISSN 1879-0852 (Vol. 82, Sep. 2017, str. 237-246)Type of material - e-article ; adult, seriousPublish date - 2017Language - englishCOBISS.SI-ID - 6254655
Author
Gligorov, Joseph |
Ataseven, B. |
Verrill, M. |
De Laurentiis, Michelino |
Jung, K. H. |
Azim, Hatem A. |
Al-Sakaff, N. |
Lauer, S. |
Shing, M. |
Pivot, Xavier
Other authors
Takač, Iztok
Topics
Breast neoplasms |
Drug therapy |
Metabolism |
Novotvorbe dojk |
Zdravljenje z zdravili |
Metabolizem |
Chemotherapy, adjuvant |
Adjuvantna kemoterapija |
Antineoplastic agents |
Antineoplastiki |
Trastuzumab |
Trastuzumab |
Receptor, ErbB-2 |
ErbB-2 receptor |
Injections, subcutaneous |
Podkožne injekcije |
Survival analysis |
Analiza preživetja
Shelf entry
Permalink
- URL:
Impact factor
Access to the JCR database is permitted only to users from Slovenia. Your current IP address is not on the list of IP addresses with access permission, and authentication with the relevant AAI accout is required.
Year | Impact factor | Edition | Category | Classification | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Select the library membership card:
DRS, in which the journal is indexed
Database name | Field | Year |
---|
Links to authors' personal bibliographies | Links to information on researchers in the SICRIS system |
---|---|
Gligorov, Joseph | |
Ataseven, B. | |
Verrill, M. | |
De Laurentiis, Michelino | |
Jung, K. H. | |
Azim, Hatem A. | |
Al-Sakaff, N. | |
Lauer, S. | |
Shing, M. | |
Pivot, Xavier | |
Takač, Iztok | 01324 |
Select pickup location:
Material pickup by post
Notification
Subject headings in COBISS General List of Subject Headings
Select pickup location
Pickup location | Material status | Reservation |
---|
Please wait a moment.